Ulrika Simonsson (@ulrikasimonsson) 's Twitter Profile
Ulrika Simonsson

@ulrikasimonsson

Prof Ulrika Simonsson leads research related to tuberculosis drug development and optimized individual dosing using pharmacometrics at Uppsala University.

ID: 1395362708

calendar_today01-05-2013 19:15:12

140 Tweet

217 Followers

304 Following

UCC unizar (@uccunizar) 's Twitter Profile Photo

Hoy es el día mundial de la tuberculosis (TB) ¿sabes cuÔnto dura el tratamiento para TB? ¿Conoces los centros de referencia para la detección de TB? Entérate en esta serie de clips #WorldTBDay #EndTB and #InvestToEndTB D2AMR Universidad Zaragoza IPKCuba OPS/OMS Cuba

UCC unizar (@uccunizar) 's Twitter Profile Photo

La tuberculosis es una enfermedad de las vías respiratorias y se transmite igual que el COVID-19. Esta enfermedad puede ser mortal si no es tratada y el tratamiento dura mínimo 6 meses. ¿Tienes mÔs dudas? INCMNSZ FZ Borstel TB Alliance #EndTB #InvestToEndTB #WorldTBDay

Farmaceutiska fakulteten (@ffakulteten) 's Twitter Profile Photo

The Faculty of Pharmacy, Lab Ulrika Simonsson and ERA4TB Project commemorates World #TuberculosisDay 24 March to raise public awareness of the consequences of tuberculosis, a disease in which 1.5 million die each year

Ulrika Simonsson (@ulrikasimonsson) 's Twitter Profile Photo

Exciting days in München with #UNITE4TB, summarizing our first year together to #EndTB through this 185mEuro #IMI_JU project

Ulrika Simonsson (@ulrikasimonsson) 's Twitter Profile Photo

Special issue in CPT:PSP on Quantitative Approaches to Drug Safety is out! Check out our contribution! doi.org/10.1002/psp4.1… ASCPT Journal Family UNITE4TB Lina Keutzer #EndTB #LabSimonsson

Ulrika Simonsson (@ulrikasimonsson) 's Twitter Profile Photo

Department excursion with archaeology researcher. To learn more about the Viking and Iron Age period of Uppsala @UU_University #historyfacts #Education #beautifulworld

Ulrika Simonsson (@ulrikasimonsson) 's Twitter Profile Photo

Our review article is out! ⁦Thanks for a great team work! @JustinWilkins⁩ ⁦Elin Svensson⁩ and all co-authors #EndTB #pharmacometrics sciencedirect.com/science/articl…

ERA4TB Project (@imi_era4tb) 's Twitter Profile Photo

39 data sources are available on the ERA4TB Platform. All details are being presented today at the 5th Consortium meeting and are available on the First Report on Clinical and preclinical datasets šŸ‘‰era4tb.org/wp-content/upl… #Tuberculosis #EUHealthResearch #H2020

39 data sources are available on the ERA4TB Platform. All details are being presented today at the 5th Consortium meeting and are available on the First Report on Clinical and preclinical datasets

šŸ‘‰era4tb.org/wp-content/upl…

#Tuberculosis #EUHealthResearch #H2020
Ulrika Simonsson (@ulrikasimonsson) 's Twitter Profile Photo

It was my pleasure to present in this session outlying our pharmacometrics approach to Hollow Fibre System design and analysis together with Santi Ramon-Garcia UCC unizar ERA4TB Project #LabSimonsson #ENDTB #MID3

ERA4TB Project (@imi_era4tb) 's Twitter Profile Photo

Our partners FZ Borstel BIOASTER and Istituto Applicazioni del Calcolo, hosted by Institut Pasteur, since 1887, have led the satellite workshop today providing a big picture of the use and needs of biomarkers treatment efficacy in clinic #Tuberculosis #EUHealthResearch #H2020

Our partners <a href="/FZBorstel/">FZ Borstel</a> <a href="/BIOASTER/">BIOASTER</a> and <a href="/CNRIAC/">Istituto Applicazioni del Calcolo</a>, hosted by <a href="/institutpasteur/">Institut Pasteur, since 1887</a>, have led the satellite workshop today providing a big picture of the use and needs of biomarkers treatment efficacy in clinic

#Tuberculosis #EUHealthResearch #H2020
ERA4TB Project (@imi_era4tb) 's Twitter Profile Photo

Today, the 6th Consortium Meeting of ERA4TB started with an overview of the pipeline status and discussions on each asset’s progression #Tuberculosis #EUHealthResearch #H2020

Today, the 6th Consortium Meeting of ERA4TB started with an overview of the pipeline status and discussions on each asset’s progression

#Tuberculosis #EUHealthResearch #H2020